| Literature DB >> 35139914 |
Anna M Carapellotti1, Matthew Rodger2, Michail Doumas2.
Abstract
BACKGROUND: Community-based dance programs for people living with Parkinson's have grown in popularity over the past two decades. Studies investigating these programs have demonstrated multidimensional benefits in motor, non-motor, and quality of life related outcomes, yet there is a need to focus on the feasibility of larger trials. The primary objective of this study was to assess the feasibility and acceptability of conducting a trial investigating dance and Parkinson's in Northern Ireland. The secondary objectives were to conduct preliminary analyses of the classes' effects and to assess the appropriateness of outcome measures for a randomized controlled trial.Entities:
Keywords: Dance; Feasibility study; Parkinson’s disease; Quality of life
Year: 2022 PMID: 35139914 PMCID: PMC8827282 DOI: 10.1186/s40814-022-00982-9
Source DB: PubMed Journal: Pilot Feasibility Stud ISSN: 2055-5784
Details of responses of people living with Parkinson’s (n = 282) to PPI survey
| Q. Do you think people would be more willing to participate if the study involved taking [dance] classes once or twice per week? | Once per week (141, 50%) |
| Twice per week (41, 14.5%) | |
| Either (100, 35.5%) | |
| Q. What would you expect to be the main barriers to participation in this research? Please select up to 2 options. | Transportation (150, 53.2%) |
| Scheduling conflicts (137, 48.5%) | |
| Work/employment (40, 14.2%) | |
| Symptoms (51, 18.1%) | |
| I wouldn't expect there to be any barriers (29, 10.3%) | |
| Lack of interest (18, 6.4%) | |
| Stress imposed on carer (9, 3.2%) | |
| Other (34, 12.1%) Barriers specified (paraphrased): Location (14), Fear, embarrassment, shyness (5), Perceptions of dance (4), Other commitments (3), Cost (2), Lack confidence (2), Stress (1), No partner (1), Gender (1), Motivation (1), Group assignment (1) | |
| Q. Before and after the 8-12 week intervention, participants […] will complete a series of physical and cognitive tests at the university. These would take a total of 90-120 minutes. Does this seem… | Too long (45, 16.0%) |
| About right (172, 61.0%) | |
| I don't know (62, 22.0%) | |
| Too short (3, 1.1%) | |
| Q. What outcome measures do you think would be most relevant and important to participants? Please select up to 3 that you think would be most important. | Balance (192, 68.1%) |
| Walking ability (144, 51.1%) | |
| Cognitive abilities (113, 40.1%) | |
| Motor symptom severity (102, 36.2%) | |
| Mood (94, 33.3%) | |
| Endurance (61, 30.5%) | |
| Non-motor experiences of daily living (39, 13.8%) | |
| Motor experiences of daily living (71, 25.2%) | |
| None are relevant (1, 0.3%) | |
| Other (72, 25.5%) Outcomes suggested (paraphrased): Social benefits/impact (14), All (6), Posture (4), Self-worth/esteem, achievement (4), Medication (3), Sleep (3), Wellbeing (2), Coordination (2), Enjoyment of classes (1), Pain (1), Speech (1), QOL (1), Dexterity (1), Rigidity/flexibility (1), Self-management (1), Motivation (1), Independence (1) | |
| Q. In this study, do you think we should assess participants when they are taking their medication as usual, or should we ask them to withhold their medication for 12 hours prior to the assessments? | On medication (211, 74.8%) |
| Off medication, (0, 0%) | |
| No preference (71, 25.2%) | |
| Q. As well as capturing standard outcome measures, we want to understand people's experiences of the programmes. What would be the best way of capturing this? | Face-to-face interview (85, 30.1%) |
| Diary (62, 22.0%) | |
| Phone interview (57, 20.2%) | |
| Survey (31, 11.0%) | |
| Focus group (28, 9.9%) | |
| Other (19, 6.7%) Suggestions (paraphrased): Options, combination, or all of the above (10), Email (1), Video call (1), Diary with specific questions (1) |
Data presented is the number of responses and percentage of 282 survey participants (no., %). Other suggestions/comments have been paraphrased and organized thematically for brevity; unclear or irrelevant comments were not included in the table
Fig. 1CONSORT participant flow diagram. The number of participants approached is not included in this diagram because, due to a primary strategy of disseminating information about the study in the community, it is not possible to report the number of prospective participants reached during the recruitment stage
Characteristics of participants
| Participant | Age, years | Sex | Education, years | PD duration, years | H&Y | Medications |
|---|---|---|---|---|---|---|
| 1 | 70 | F | 18 | 3 | 2 | C/L |
| 2 | 67 | M | 18 | 5 | 1 | C/L, Ras, Rop |
| 3 | 66 | M | 18 | 9 | 1.5 | C/L, Ras, Rop |
| 4 | 53 | M | 12 | 3 | 2.5 | C/L |
| 5 | 72 | M | 16 | 1 | 1 | C/L, Rot. |
| 6 | 72 | M | 19 | 2 | 2 | C/L |
| 7 | 68 | M | 16 | 5 | 1.5 | C/L, Ras, Rop |
PD Parkinson’s disease, H&Y modified Hoehn and Yahr Stage, C/L Carbidopa/levodopa, Ras. Rasagiline, Rop. Ropinirole, Rot. Rotigotine
Results for Parkinson’s Disease Quality of Life Scale (PDQ-39)
| Dimension | Pre-test | Post-test | Effect size | |
|---|---|---|---|---|
| Mobility | 37.50 ± 40.00 (2.50, 77.50) | 25.00 ± 30.00 (2.50, 67.50) | 0.058 | − 1.000 |
| ADLs | 41.67 ± 41.67 (16.67, 87.50) | 33.33 ± 37.50 (8.33, 95.83) | 0.235 | − 0.536 |
| Emotional Well− Being | 29.17 ± 29.17 (4.17, 45.83) | 12.50 ± 20.83 (4.17, 66.67) | 0.410 | − 0.467 |
| Stigma | 12.50 ± 18.75 (0, 43.75) | 12.50 ± 12.50 (0, 62.50) | 0.890 | − 0.133 |
| Social Support | 8.33 ± 25.00 (0, 41.67) | 0 ± 33.33 (0, 41.67) | 0.423 | − 0.667 |
| Cognition | 31.25 ± 31.25 (12.50, 68.75) | 18.75 ± 6.25 (18.75, 68.75) | 0.170 | − 0.733 |
| Communication | 25.00 ± 25.00 (8.33, 50.00) | 16.67 ± 16.67 (0, 41.67) | 0.396 | − 0.393 |
| − | ||||
| Summary Index | 26.56 ± 20.63 (11.25, 57.08) | 16.25 ± 19.38 (10.21, 63.91) | 0.078 | − 0.786 |
Wilcoxon signed-rank test. Scores reported are medians and interquartile ranges. A decrease in score indicates improvement. Effect size reported is the Rank-biserial correlation
Results for motor outcomes
| Outcome | Pre-test | Post-test | Change score | Effect size | |
|---|---|---|---|---|---|
| MDS-UPDRS-IIIa | 28.57 (14.36) | 23.71 (10.52) | − 4.86 | 0.072 | − 0.823 |
| − | − | ||||
| DT-TUG (sec)b | 12.48 (2.32) | 11.76 (2.67) | − 0.72 | 0.327 | − 0.429 |
| FOG-Qb | 5.14 (2.80) | 4.86 (3.39) | − 0.28 | 0.589 | − 0.286 |
| FES-Ib | 31.71 (11.83) | 30.71 (11.38) | − 1.00 | 0.833 | − 0.143 |
| SOTa | 69.71 (5.94) | 73.00 (4.40) | 3.29 | 0.236 | 0.498 |
| SOT-E1a | 93.38 (1.08) | 92.38 (2.70) | − 1.00 | 0.180 | − 0.574 |
| SOT-E2a | 90.76 (2.46) | 90.38 (1.86) | − 0.38 | 0.740 | − 0.131 |
| SOT-E3a | 90.71 (3.47) | 90.10 (3.43) | − 0.61 | 0.644 | − 0.184 |
| SOT-E4a | 73.52 (7.20) | 78.67 (5.77) | 5.15 | 0.116 | 0.695 |
| SOT-E5a | 49.48 (21.13) | 54.33 (9.56) | 4.85 | 0.446 | 0.308 |
| SOT-E6a | 46.48 (13.32) | 56.52 (15.14) | 10.04 | 0.290 | 0.439 |
Pre- and post-test values presented are means and standard deviations
MDS-UPDRS-III Movement Disorder Society United Parkinson’s Disease Rating Scale Part III, TUG Timed Up and Go Test, DT-TUG Dual-Task Timed Up and Go (cognitive), FOG-Q Freezing of Gait Questionnaire, FES-I Falls Efficacy Scale International, SOT Sensory Organization Test Composite Score, E1 eyes open firm surface, E2 eyes closed on firm surface, E3 eyes open with sway referenced visual surround, E4 eyes open on sway referenced support surface, E5 eyes closed on sway referenced support surface, E6 eyes open on sway referenced support surface and surround
aData were analyzed using Student’s t test. Effect size reported is Cohen’s d
bData were analyzed using the Wilcoxon Signed Rank test. Effect size reported is the Rank-biserial correlation
Results for non-motor outcomes
| Outcome | Pre-test | Post-test | Change score | Effect size | |
|---|---|---|---|---|---|
| − | − | ||||
| MoCA | 26.71 (1.89) | 27.43 (1.51) | 0.72 | 0.671 | − 0.238 |
| Trail A (sec) | 49.91 (12.69) | 43.90 (14.24) | − 6.01 | 0.219 | 0.571 |
| Trail B (sec) | 92.47 (23.12) | 99.76 (32.04) | 7.29 | 0.578 | − 0.286 |
| DS Forward | 11.14 (2.55) | 11.43 (1.81) | 0.29 | 0.798 | − 0.143 |
| DS Backward | 6.43 (3.55) | 7.00 (2.94) | 0.57 | 0.526 | − 0.333 |
| DS Total | 17.57 (4.32) | 18.43 (4.58) | 0.86 | 0.400 | − 0.429 |
| DSST | 50.71 (11.90) | 51.43 (12.38) | 0.72 | 0.865 | − 0.107 |
Non-motor outcomes were analyzed using the Wilcoxon-signed rank test. Pre- and post-test values presented are means and standard deviations. Effect size reported is the Rank-biserial correlation
PHQ-9 Patient Health Questionnaire 9, MoCA Montreal Cognitive Assessment, Trail A Trail Making Test Part A, Trail B Trail Making Test Part B, DS Digit Span, DSST Digit Symbol Substitution Test
Participant responses to Exit Questionnaire
| Questionnaire Item | Median (1st, 3rd quartiles) |
|---|---|
| I enjoyed the program | 1 (1.00, 1.00) |
| Balance improved | 2 (2.00, 2.50) |
| Walking improved | 3 (2.00, 3.00) |
| Coordination improved | 2 (2.00, 2.50) |
| Strength improved | 2 (1.00, 2.50) |
| Flexibility improved | 2 (1.50, 2.50) |
| Mood improved | 2 (2.00, 2.00) |
| Aches/pains improved | 3 (1.50, 3.00) |
| I would continue | 1 (1.00, 1.50) |
| I use ideas/skills learned in class in ADLs | 2 (1.50, 2.00) |
Participants rated each item on the Exit Questionnaire on a scale of one to five. 1, Strongly agree, 2, Somewhat agree, 3, Neither agree nor disagree, 4, Somewhat disagree, 5, Strongly disagree
ADLs Activities of daily living